このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

AI Voice Calls Versus Text and Email Reminders for Questionnaire Response After Shoulder Arthroplasty (VOICE-REACH)

Proactive Conversational Artificial Intelligence Calls Versus Digital Reminders to Collect Patient-Reported Outcomes After Shoulder Arthroplasty: A Randomized Study Within a Multicenter Cohort

After shoulder replacement surgery, surgeons send questionnaires to their patients to learn how they are doing (pain, shoulder function, satisfaction). Many patients do not answer. This study tests the best way to obtain these answers.

The study is nested in a multicenter study of pain after shoulder arthroplasty conducted in four French centers (host study RetroPAinRSACAll, supported by Ramsay Santé). The clinical results of the host study are not the subject of this registration: this study evaluates only the method used to collect the information.

All patients first receive an email invitation (when an email address is available) and, the next day, a text message (SMS) with a personal link to the questionnaire and a phone number to answer at any time by talking with an automated voice assistant. Patients who have not answered two days after the first contact are randomly assigned to one of two follow-up strategies: (1) further digital reminders (SMS on day 3 and day 5, email on day 7), or (2) up to three phone calls from a conversational artificial intelligence (AI) voice agent on days 3, 5 and 7, which asks the same questions orally. In both groups, patients can answer at any time online or by calling the voice assistant, and contacts stop as soon as the questionnaire is completed or the patient refuses.

The main outcome is the proportion of patients who complete the questionnaire within 14 days of the first contact.

調査の概要

状態

募集

条件

介入・治療

詳細な説明

Design. VOICE-REACH is a pragmatic, multicenter, individually randomized, two-arm, open-label superiority study within a trial (SWAT). It is embedded in the host study RetroPAinRSACAll (persistent pain after shoulder arthroplasty, four French shoulder surgery centers, favorable opinion of the Ramsay Santé scientific committee, reference COS-RGDS-2026-07-008). All patients of the host cohort are contacted through the DeepCall platform on behalf of their surgeon to complete the host study questionnaire (operation details, warning signs, pain screening and characterization, rehabilitation and function including the Subjective Shoulder Value, opinion on the operation and on the contact). The comparison concerns the follow-up strategy only: the questionnaire is the same in both arms and the same on the web and by voice.

Common phase (all participants). Day 0: email invitation with a personal questionnaire link, sent when an email address is available. Day 1: SMS with the same link, the phone number of the AI voice agent (available 24 hours a day for inbound calls) and an opt-out option (reply NO). Patients are contacted in successive waves of up to 450 patients, one day apart, to respect operator sending limits; all study days are counted from each participant's own day 0.

Randomization. On day 2, participants who have not completed the questionnaire and have not refused are randomized 1:1 by the platform, using a computer-generated permuted block sequence (blocks of 4) stratified by center. Participants who completed the questionnaire before day 2 are not randomized and are described separately.

Arm A, digital reminders: SMS reminders on day 3 and day 5 and an email reminder on day 7 (when an email address is available).

Arm B, proactive AI calls: outbound calls from the AI voice agent on day 3, day 5 and day 7 (up to three attempts). The agent calls on behalf of the surgeon's team and asks the questionnaire orally; answers are extracted into the same structured fields as the web form.

In both arms, the web link and the inbound voice line remain available throughout, and all scheduled contacts stop as soon as the questionnaire is completed, the patient refuses, or the patient is identified as deceased. Warning signs reported by patients are flagged to the surgical team for review; the AI agent does not give medical advice.

Analysis. The primary analysis is intention to treat among all randomized participants: proportion with a completed questionnaire by day 14, risk difference (Arm B minus Arm A) with 95% confidence interval, adjusted for center and email availability. Participants without a completed questionnaire by day 14 are counted as non-completers; no answer is imputed. Secondary analyses describe the yield of the common phase, time to completion, completion channel, partial responses, refusals, number of contacts and cost per completed questionnaire, acceptability of the contact mode among responders, representativeness of responders, and the accuracy of voice-captured answers.

Registration timing. The common pre-randomization outreach started on 9 November 2026. This record was created on 10 November 2026, before the first randomization (day 2 of the first wave, 11 November 2026).

研究の種類

介入

入学 (推定)

846

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

      • Caen、フランス、14000
        • 募集
        • Hôpital Privé Saint-Martin
        • 主任研究者:
          • Franck Dordain, MD
      • Lyon、フランス、69008
        • 募集
        • Centre Orthopédique Santy, Hôpital Privé Jean Mermoz
        • 主任研究者:
          • Arnaud Godenèche, MD
      • Paris、フランス、75019
        • 募集
        • Clinique des Maussins-Nollet
        • 主任研究者:
          • Geoffroy Nourissat, MD, PhD
      • Strasbourg、フランス、67000
        • 募集
        • Clinique de l'Orangerie
        • 主任研究者:
          • Maxime Antoni, MD

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Age 18 years or older
  • Shoulder arthroplasty (reverse, anatomic, humeral head replacement or revision arthroplasty) performed at one of the four participating centers and listed in the host study cohort
  • At least one telephone number available (an email address is not required)

Additional criteria for randomization (day 2):

* Questionnaire not completed and no refusal at the day-2 cutoff

Exclusion Criteria:

  • Death identified before the first contact (cross-check with the French national death registry, INSEE)
  • Duplicate record
  • Refusal of contact
  • Questionnaire already completed before day 2 (excluded from randomization only, described separately)

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:ヘルスサービス研究
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Digital Reminders

Common phase: email invitation on day 0 (if an email address is available) and SMS invitation on day 1 with the questionnaire link and the AI voice agent phone number. After randomization on day 2: SMS reminder on day 3, SMS reminder on day 5 and email reminder on day 7 (if an email address is available). Participants can answer at any time by web link or by calling the AI voice agent. Contacts stop at completion or refusal.

Standardized reminder messages sent by the DeepCall platform on behalf of the surgeon: SMS on day 3 and day 5 and email on day 7 (if an email address is available), each with the personal questionnaire link, the AI voice agent phone number and an opt-out option.

実験的:Proactive AI Voice Calls

Same common phase (email on day 0 if available, SMS on day 1). After randomization on day 2: up to three outbound calls from the conversational AI voice agent on day 3, day 5 and day 7, during which the same questionnaire is asked orally. Participants can also answer at any time by web link or by calling the AI voice agent. Contacts stop at completion or refusal.

Outbound telephone calls placed by a conversational AI voice agent (DeepCall platform) on day 3, day 5 and day 7, up to three attempts. The agent calls on behalf of the surgeon's team, conducts the same questionnaire orally and records the answers in the same structured fields as the web form.

他の名前:
  • DeepCall

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Questionnaire Completion by Day 14 Among Randomized Participants
時間枠:From day 0 (first contact) to day 14

Proportion of randomized participants with a completed questionnaire within 14 days of their first contact (day 0), whatever the channel used (web link, inbound call or outbound AI call). A questionnaire is complete when it was submitted on the web or when all required items were answered during a voice interview. Participants without a completed questionnaire at the day-14 cutoff are counted as non-completers. Compared between arms (proactive AI voice calls minus digital reminders).

From day 0 (first contact) to day 14

二次結果の測定

結果測定
メジャーの説明
時間枠
Questionnaire Completion by Day 7 Among Randomized Participants
時間枠:From day 0 to day 7

Proportion of randomized participants with a completed questionnaire by day 7, whatever the channel used.

From day 0 to day 7
Time to Questionnaire Completion
時間枠:From day 2 to day 14

Time in hours from randomization (day 2) to questionnaire completion among randomized participants; participants without a completed questionnaire are censored at day 14.

From day 2 to day 14
Questionnaire Completion Before Randomization
時間枠:From day 0 to day 2

Proportion of all enrolled participants who completed the questionnaire after the common email (day 0) and SMS (day 1) invitations, before the day-2 randomization.

From day 0 to day 2
Questionnaire Completion by Day 14 in All Enrolled Participants
時間枠:From day 0 to day 14

Proportion of all enrolled participants, randomized or not, with a completed questionnaire by day 14.

From day 0 to day 14
Partial Questionnaire Response
時間枠:From day 0 to day 14

Proportion of randomized participants who answered at least one question without completing the questionnaire by day 14.

From day 0 to day 14
Completion Channel
時間枠:From day 0 to day 14

Distribution of completed questionnaires by channel (web link, inbound call to the voice agent, outbound AI call), by arm.

From day 0 to day 14
Refusal of Contact
時間枠:From day 2 to day 14

Proportion of randomized participants who explicitly refused further contact (SMS reply, email refusal link or refusal during a call).

From day 2 to day 14
Number of Contacts per Completed Questionnaire
時間枠:From day 0 to day 14

Number of emails, SMS and outbound calls sent or attempted, divided by the number of completed questionnaires, by arm.

From day 0 to day 14
Direct Cost per Completed Questionnaire
時間枠:From day 0 to day 14

Direct costs of messaging, telephony and AI processing (euros) divided by the number of completed questionnaires, by arm, and incremental cost per additional completed questionnaire.

From day 0 to day 14
Satisfaction With the Mode of Contact
時間枠:From day 0 to day 14

Among participants who completed the questionnaire: satisfaction with the way they were contacted, rated on a 5-level scale from very satisfied to very dissatisfied.

From day 0 to day 14
Perceived Number of Contacts
時間枠:From day 0 to day 14

Among participants who completed the questionnaire: perceived number of contacts (too many, appropriate, too few).

From day 0 to day 14
Preferred Contact Mode for Future Follow-up
時間枠:From day 0 to day 14

Among participants who completed the questionnaire: preferred mode of contact for future follow-up questionnaires (categorical).

From day 0 to day 14
Characteristics of Responders Versus Non-Responders
時間枠:Day 14

Age, center, type of arthroplasty and time since surgery (when available in the host cohort) compared between participants who completed the questionnaire and those who did not, by arm (standardized differences).

Day 14
Agreement Between Voice-Captured Answers and Human Review
時間枠:From day 0 to day 14

In a random sample of completed voice interviews, agreement between the answers extracted by the AI agent and those coded by a reviewer listening to the recording, blinded to the extracted values (percentage agreement, kappa or intraclass correlation coefficient).

From day 0 to day 14

その他の成果指標

結果測定
メジャーの説明
時間枠
Delivery of Email and SMS Invitations
時間枠:From day 0 to day 7

Proportion of emails and SMS delivered, bounced or filtered by the operator, as reported by the sending providers.

From day 0 to day 7
Outbound Call Outcomes
時間枠:From day 3 to day 7

Distribution of outbound AI call outcomes (answered, voicemail, no answer, filtered, failed) and call duration in the proactive AI voice calls arm.

From day 3 to day 7

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

協力者

捜査官

  • 主任研究者:Jules Descamps, MD, MSc、Hopital Lariboisière
  • スタディチェア:Geoffroy Nourissat, MD, PhD、Clinique des Maussins-Nollet, Ramsay Santé

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年11月9日

一次修了 (推定)

2026年11月24日

研究の完了 (推定)

2026年11月24日

試験登録日

最初に提出

2026年11月10日

QC基準を満たした最初の提出物

2026年11月10日

最初の投稿 (実際)

2026年11月17日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月17日

QC基準を満たした最後の更新が送信されました

2026年11月10日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • VOICE-REACH

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Identifiable data, call recordings and transcripts will not be shared. Aggregated results will be published.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。